Dept. of Marketing and Communications
Sehen Sie dies auf Deutsch.
IPS Expands in the DACH Region with Newly Established Operations in Germany
- Meeting the needs of life sciences clients by offering subject matter expertise and single-source EPCMV project delivery services worldwide -
IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation (EPCMV) services, announces the continued expansion in Europe, specifically the DACH region consisting of Germany, Austria, and Switzerland, with the opening of a new office located in Frankfurt, and with operations in Nuremberg, Germany.
IPS’ German operations, under the leadership of Senior Director Mr. Helmut Steudel, will offer the full array of EPCMV services to the pharmaceutical and biotechnology industry. With the growing need to diversify the pool of mature service providers, IPS brings technical innovation, subject matter expertise, and a depth of industry resources across the DACH, EMEA and global business units focused in the life sciences market sector.
“Proximity to our clients is a key element of project success and a catalyst for continued growth,” stated Helmut Steudel, Senior Director – German Operations. “By investing in local resources, offering our technical expertise and comprehensive EPCMV services, we can serve the growing number of projects and opportunities in this area.”
As part of IPS’ growth strategy, the German operations complement the company’s offices in Switzerland, Ireland, and its regional headquarters in the UK. With an existing client base and a portfolio of successful projects in the DACH region, IPS is well-positioned to be the premier local service provider focused on the life sciences industry.
Dave Goswami, IPS Chairman and Chief Executive Officer, stated, “The establishment of our German operations fits into our long-term plan for continued growth in the EMEA region. Between the Frankfurt office and Nuremberg operations, we can serve the growing number of projects and opportunities in the region. We will leverage our strong pharmaceutical and biotechnology expertise with the exceptionally skilled work-force in this country to serve our clients throughout the DACH region.”
Download this full announcement here.